BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17571566)

  • 21. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
    Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH
    Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serous tumors of low malignant potential of the ovary. 1. Diagnostic pathology.
    Dietel M; Hauptmann S
    Virchows Arch; 2000 May; 436(5):403-12. PubMed ID: 10881733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ovarian tumors of low malignant potential (borderline ovarian tumors)].
    Luchian AM; Pricop M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):438-45. PubMed ID: 21870737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases.
    Djordjevic B; Malpica A
    Am J Surg Pathol; 2010 Jan; 34(1):1-9. PubMed ID: 19898226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.
    Emerson RE; Wang M; Liu F; Lawrence WD; Abdul-Karim FW; Cheng L
    Int J Gynecol Pathol; 2007 Oct; 26(4):387-94. PubMed ID: 17885488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.
    Hogg R; Scurry J; Kim SN; Friedlander M; Hacker N
    Gynecol Oncol; 2007 Jul; 106(1):44-51. PubMed ID: 17467045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro fertilization following conservative management of stage 3 serous borderline tumor of the ovary.
    Hoffman JS; Laird L; Benadiva C; Dreiss R
    Gynecol Oncol; 1999 Sep; 74(3):515-8. PubMed ID: 10479523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serous borderline tumours of the ovary.
    Kurman RJ; Seidman JD; Shih IM
    Histopathology; 2005 Sep; 47(3):310-5. PubMed ID: 16115232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serous tumours of low malignant potential (serous borderline tumours): moving toward détente.
    Longacre TA; Kempson RL; Hendrickson MR
    Histopathology; 2005 Sep; 47(3):315-8. PubMed ID: 16115233
    [No Abstract]   [Full Text] [Related]  

  • 31. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas.
    Bell KA; Smith Sehdev AE; Kurman RJ
    Am J Surg Pathol; 2001 Apr; 25(4):419-32. PubMed ID: 11257616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators.
    Seidman JD; Kurman RJ
    Hum Pathol; 2000 May; 31(5):539-57. PubMed ID: 10836293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Borderline epithelial tumors of the ovary.
    Hart WR
    Mod Pathol; 2005 Feb; 18 Suppl 2():S33-50. PubMed ID: 15761465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathology and classification of ovarian tumors.
    Chen VW; Ruiz B; Killeen JL; Coté TR; Wu XC; Correa CN
    Cancer; 2003 May; 97(10 Suppl):2631-42. PubMed ID: 12733128
    [No Abstract]   [Full Text] [Related]  

  • 35. Glomeruloid peritoneal implants in ovarian serous borderline tumours--distinction between invasive and non-invasive implants and pathogenesis.
    Lee ES; Leong AS; Kim IS; Kim YS; Lee JH; Cho HY
    Histopathology; 2009 Nov; 55(5):505-13. PubMed ID: 19912356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic difficulties in serous "borderline" tumors of the ovary].
    Vereczkey I; Tóth E; Orosz Z
    Magy Onkol; 2009 Mar; 53(1):23-31. PubMed ID: 19318323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucinous tumors of the ovary: a review.
    Hart WR
    Int J Gynecol Pathol; 2005 Jan; 24(1):4-25. PubMed ID: 15626914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serous borderline tumors of the ovary.
    Prat J
    Adv Clin Path; 1997 Apr; 1(2):97-102. PubMed ID: 10352473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors for patients with advanced stage serous borderline tumours of the ovary.
    Morice P; Camatte S; Rey A; Atallah D; Lhommé C; Pautier P; Pomel C; Coté JF; Haie-Meder C; Duvillard P; Castaigne D
    Ann Oncol; 2003 Apr; 14(4):592-8. PubMed ID: 12649107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.